Denali Therapeutics Inc. (DNLI) PT Raised to $42 at H.C. Wainwright

March 26, 2026 8:35 AM

H.C. Wainwright analyst Andrew Fein raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $42.00 (from $32.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found